MOGN
Mgi Pharma Inc
Biopharmaceutical company focused on oncology and acute care therapeutics, commercializing products including Aloxi, Dacogen and Gliadel
CUSIP: 552880106HealthcareUS1 holder
Mgi Pharma Inc
Biopharmaceutical company focused on oncology and acute care therapeutics, commercializing products including Aloxi, Dacogen and Gliadel
No insider transactions reported in the last year. Look across all recorded history →